(Q44452696)

3 December 2017

Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement? (English)

1 reference

3 December 2017

3

G Y H Lip

1 reference

3 December 2017

G I Varughese

1

1 reference

PubMed ID

16617307

3 December 2017

J V Patel

series ordinal

2

1 reference

3 December 2017

13 April 2006

1 reference

Journal of Human Hypertension

3 December 2017

1 reference

3 December 2017

20

1 reference

3 December 2017

9

1 reference

3 December 2017

635-637

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002029

3 December 2017

0 references

cites work

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Diabetes and hypertension physiopathology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Novel concepts of statin therapy for cardiovascular risk reduction in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Assessing the impact of complications on the costs of Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

How well are hypertension and albuminuria treated in type II diabetic patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Facing the diabetes epidemic--mandatory reporting of glycosylated hemoglobin values in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Diabetes and the quality and outcomes framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Determinants of primary medical care quality measured under the new UK contract: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Diabetes and the quality and outcomes framework: diabetes needs reintegration of primary and secondary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

Blood pressure measurement in diabetes clinic: are we paying enough attention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

7 January 2021

Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

7 January 2021

Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

7 January 2021

Emergence of structural arterial stiffness in diabetes and the role of abnormalities of autonomic tone in the sequence of events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

7 January 2021

Linking physicians' pay to the quality of care--a major experiment in the United kingdom

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002029

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1002029

1 reference

3 December 2017

1 reference

PubMed ID

16617307